News

CLINUVEL
Posted by CLINUVEL
October 22, 2021

First Patient Treated in CLINUVEL DNA Repair Study

Melbourne, Australia, 22 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 18, 2021

CLINUVEL Investor webinar

CLINUVEL PHARMACEUTICALS LTD today announced an Investor Webinar shall be held on...

Read More
CLINUVEL
Posted by CLINUVEL
October 8, 2021

Appendix 4G & Corporate Governance Statement

Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 8, 2021

CLINUVEL PHARMACEUTICALS LTD 2021 Annual General Meeting - Notice of Meeting & Explanatory Memorandum

Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 7, 2021

Operations Update II

Melbourne, Australia, 07 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 7, 2021

Operations Update Webcast II

Melbourne, Australia, 07 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
October 5, 2021

CLINUVEL Progresses DNA Repair Program

Melbourne, Australia, 05 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
September 23, 2021

CLINUVEL Key Events and Announcements

Melbourne, Australia, 23 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
September 22, 2021

CLINUVEL Confirms AGM Date

Melbourne, Australia, 22 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
September 16, 2021

Notification regarding unquoted securities - CUV

Melbourne, Australia, 16 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...

Read More